We congratulate Addex, Dr. Ellen Hess, and BSDPF on their exciting recent news about the potential of dipraglurant for individuals with paroxysmal dystonia and dyskinesias (PDD).
The promise this holds for those who are impacted by this rare dystonia is to be celebrated by everyone in the dystonia community. What we can learn from this recent good news may hold promise for continued progress in developing other treatments for other forms of dystonia.
Congratulations and thank you to all who have been working on this over the past several years. Working together is the only way we will conquer dystonia.